Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-03-02Phase II Trial of Depsipeptide (NSC 630176) in Advanced Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2016-02-25A Phase 3, Randomized, Double-Blind Study of BMS-936558 vs Dacarbazine in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2016-02-22Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
-
CLINICAL_TRIALS study record update · 2016-02-11Phase II Study of Genasense-Carboplatin-Paclitaxel-Combination in Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2016-02-01Phase II Evaluation of Concurrent Ipilimumab Therapy and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Malignant Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-02-01Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
-
CLINICAL_TRIALS study record update · 2016-01-28ClinicalTrials.gov study NCT02101008
-
CLINICAL_TRIALS study record update · 2016-01-25Phase I-II Pilot Study to Evaluate the Immune-mediated Effects of an Autologous Tumor-derived Heat Shock Protein-peptide Complex 96 (HSPPC-96) Combined With Ipilimumab in Patients With Therapeutically Unresectable Stage III or Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2016-01-25A Multicenter Phase II Study of Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases
-
CLINICAL_TRIALS study record update · 2016-01-21Phase II Study to Evaluate the Safety, Tolerability and Efficacy of CT-011 Administered Intravenously to Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2016-01-20Assessing the Patient Experience in Cancer Care: An Observational Communication Study
-
CLINICAL_TRIALS study record update · 2016-01-14A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-28A Phase I Dose-escalation Trial of vvDD-CDSR (Double-deleted Vaccinia Virus Plus CD/ SMR) Administered by Intratumoral Injection or Intravenous Injection
-
CLINICAL_TRIALS study record update · 2015-12-18Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo
-
CLINICAL_TRIALS study record update · 2015-12-18An Extension Protocol to Evaluate the Efficacy and Safety of Extended Use Treatment With OncoVEX^GM-CSF for Eligible Melanoma Patients Participating in Study 005/05
-
CLINICAL_TRIALS study record update · 2015-12-18A Phase II Study of the Efficacy, Safety and Immunogenicity of OncoVEX^GM-CSF in Patients With Stage IIIc and Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-17Phase 2 Extension Protocol for Extended Use of OncoVEX^GM-CSF for Eligible Patients Participating in Study 002/03: Study of the Efficacy, Safety and Immunogenicity of OncoVEX^GM-CSF in Patients With Stage IIIc and Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-17A Randomized Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Treatment With OncoVEX^GM-CSF Compared to Subcutaneously Administered GM-CSF in Melanoma Patients With Unresectable Stage IIIb, IIIc and IV Disease
-
CLINICAL_TRIALS study record update · 2015-12-14Phase II Study of MS-275, a Histone Deacetylase Inhibitor, Comparing 2 Dosage Schedules in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-09A Phase II, Double-blind, Randomised Study to Assess the Efficacy of AZD6244 in Combination With Dacarbazine Compared With Dacarbazine Alone in First Line Patients With BRAF Mutation Positive Advanced Cutaneous or Unknown Primary Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-04An Open Label, Dose Escalation, Phase I Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2015-12-03A Phase I Dose Escalation Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus Plus GM-CSF) Administered by Intravenous Infusion in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-12-03Comparison of M-Vax Plus Low Dose Interleukin-2 Versus Placebo Vaccine Plus Low Dose Interleukin-2 in Patients With Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-12-03M-Vax: A Feasibility and Bio-Equivalence Study Using a DNP-Modified Autologous Melanoma Tumor Cell Vaccine as Therapy in Patients With Stage III or IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-11-30A Randomized, Open-Label, Multicenter Phase II Study of Ipilimumab Retreatment Versus Chemotherapy for Subjects With Advanced Melanoma Who Progressed After Initially Achieving Disease Control With Ipilimumab Therapy